rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/12 → 4/30/18

Funding

  • Profectus BioSciences, Inc ( Award #5R01AI09881705): $2,308,624.00